Sarcoidosis in the national veteran population: association of ocular inflammation and mortality
- PMID: 25687027
- PMCID: PMC4414801
- DOI: 10.1016/j.ophtha.2015.01.003
Sarcoidosis in the national veteran population: association of ocular inflammation and mortality
Abstract
Purpose: To describe the distribution of ocular sarcoidosis in the veteran population and to determine the association between ocular disease and all-cause mortality.
Design: Retrospective review.
Methods: The Veterans Health Administration National Patient Care Database information on medical diagnoses, date of diagnosis, age, race, gender, and Veterans Administration medical center station number for site-specific calculations for fiscal years 2010 through 2012 was collected. Mortality data were obtained from the Beneficiary Identification Records Locator Subsystem. The patient cohort was identified with a primary diagnosis of sarcoidosis using International Classification of Disease, ninth edition, code of 135 in outpatient treatment files for the study period. The sarcoidosis patients were divided into those with uveitis or orbital inflammation (defined as ocular inflammation for this study) and those without uveitis or orbital inflammation. Survival analysis was performed using the Cox proportional hazard method.
Main outcome measure: Association between ocular inflammation and 1-year mortality.
Results: Of 15 130 subjects with sarcoidosis, 3364 (22.2%) were evaluated in an eye clinic within a Veterans Administration Medical Center. Most patients were diagnosed with anterior uveitis (n = 1013; 80.7% of ocular inflammation), and the least common diagnosis was orbital granuloma (n = 28; 2.2% of ocular inflammation). Male gender was protective to the development of uveitis (estimate, 0.76; 95% confidence interval, 0.65-0.88; P = 0.0005). The overall 1-year all-cause mortality for all patients with a diagnosis of sarcoidosis was 2.0%. Ocular inflammation was associated with a decrease in 1-year all-cause mortality (simple model: hazard ratio, 0.36; P = 0.0015; complex model: hazard ratio, 0.35; P = 0.013).
Conclusions: Veterans with ocular inflammation had significantly lower 1-year all-cause mortality than those without documented ocular inflammation. The reason for this finding remains to be established.
Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
[Ocular and neuro-ophthalmic manifestations of sarcoidosis: retrospective study of 30 cases].J Fr Ophtalmol. 2013 Jun;36(6):473-80. doi: 10.1016/j.jfo.2012.06.029. Epub 2013 Mar 29. J Fr Ophtalmol. 2013. PMID: 23545336 French.
-
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.Retina. 2008 Jun;28(6):889-93. doi: 10.1097/IAE.0b013e31816576ef. Retina. 2008. PMID: 18536608
-
Age-related macular degeneration, anti-vascular endothelial growth factor agents, and short-term mortality: a postmarketing medication safety and surveillance study.Retina. 2011 Jun;31(6):1036-42. doi: 10.1097/IAE.0b013e31821dc66f. Retina. 2011. PMID: 21836410
-
[Sarcoidosis].J Fr Ophtalmol. 2019 Mar;42(3):303-321. doi: 10.1016/j.jfo.2018.06.015. Epub 2019 Mar 5. J Fr Ophtalmol. 2019. PMID: 30850198 Review. French.
-
Sarcoidosis.J Fr Ophtalmol. 2018 Dec;41(10):e451-e467. doi: 10.1016/j.jfo.2018.10.002. Epub 2018 Nov 16. J Fr Ophtalmol. 2018. PMID: 30449643 Review.
Cited by
-
Ocular sarcoidosis: new diagnostic modalities and treatment.Curr Opin Pulm Med. 2017 Sep;23(5):458-467. doi: 10.1097/MCP.0000000000000409. Curr Opin Pulm Med. 2017. PMID: 28622198 Free PMC article. Review.
-
Sarcoidosis-Related Uveitis: A Review.J Clin Med. 2023 Apr 29;12(9):3194. doi: 10.3390/jcm12093194. J Clin Med. 2023. PMID: 37176633 Free PMC article. Review.
-
Uveitis as an Open Window to Systemic Inflammatory Diseases.J Clin Med. 2021 Jan 14;10(2):281. doi: 10.3390/jcm10020281. J Clin Med. 2021. PMID: 33466638 Free PMC article.
-
The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study.Respir Med. 2021 Oct;187:106564. doi: 10.1016/j.rmed.2021.106564. Epub 2021 Aug 9. Respir Med. 2021. PMID: 34391118 Free PMC article.
-
Progress in the diagnosis of ocular sarcoidosis.Indian J Ophthalmol. 2022 Apr;70(4):1121-1129. doi: 10.4103/ijo.IJO_2830_21. Indian J Ophthalmol. 2022. PMID: 35325997 Free PMC article. Review.
References
-
- Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885–9. - PubMed
-
- Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis. 1980;122:721–4. - PubMed
-
- Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29:119–27. - PubMed
-
- Herbort CP, Rao NA, Mochizuki M members of Scientific Committee of First International Workshop on Ocular S. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS) Ocul Immunol Inflamm. 2009;17:160–9. - PubMed
-
- Takase H, Mochizuki M. The role of imaging in the diagnosis and management of ocular sarcoidosis. Int Ophthalmol Clin. 2012;52:113–20. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical